Reduced-dose IMRT appropriate for induction chemotherapy responders with HPV-associated oropharyngeal cancer

Complete clinical response to induction chemotherapy may serve as a biomarker to identify patients with HPV–associated oropharyngeal squamous cell carcinoma who could benefit from radiation deintensification, according to prospective study results.
Healio